NSE - Delayed Quote INR

Sakar Healthcare Limited (SAKAR.NS)

Compare
236.04
-6.20
(-2.56%)
At close: 3:29:40 PM GMT+5:30
Loading Chart for SAKAR.NS
  • Previous Close 242.24
  • Open 237.45
  • Bid --
  • Ask --
  • Day's Range 220.41 - 240.01
  • 52 Week Range 210.10 - 385.00
  • Volume 28,806
  • Avg. Volume 31,305
  • Market Cap (intraday) 5.134B
  • Beta (5Y Monthly) 0.06
  • PE Ratio (TTM) 34.56
  • EPS (TTM) 6.83
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

www.sakarhealthcare.com

325

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SAKAR.NS

View More

Performance Overview: SAKAR.NS

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SAKAR.NS
20.38%
S&P BSE SENSEX (^BSESN)
6.40%

1-Year Return

SAKAR.NS
36.06%
S&P BSE SENSEX (^BSESN)
1.50%

3-Year Return

SAKAR.NS
62.45%
S&P BSE SENSEX (^BSESN)
23.89%

5-Year Return

SAKAR.NS
363.28%
S&P BSE SENSEX (^BSESN)
143.25%

Compare To: SAKAR.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SAKAR.NS

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    5.27B

  • Enterprise Value

    6.00B

  • Trailing P/E

    35.43

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.08

  • Price/Book (mrq)

    1.95

  • Enterprise Value/Revenue

    3.52

  • Enterprise Value/EBITDA

    13.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.68%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.71B

  • Net Income Avi to Common (ttm)

    148.62M

  • Diluted EPS (ttm)

    6.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.27M

  • Total Debt/Equity (mrq)

    31.13%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SAKAR.NS

View More

Company Insights: SAKAR.NS

Research Reports: SAKAR.NS

View More

People Also Watch